ADA publication
VISION
We’re Changing the Way the World Thinks About Diabetes
Most of existing APS solutions are very complicated and takes lots of time and knowledge to start using them.
The key goal of OMNIA to make life with diabetes a lot easier. You need only 10 minutes to start.
About
OMNIA is a unique algorithm based application designed to protect against the possible complications associated with diabetes.
The main task of the application is to maintain glucose within the target safe range of 3.9-10 mmol / L and to avoid the occurrence of low blood glucose values (blood hypoglycemia).
OMNIA
TODAY
-
Application
Fully working app with build-in unique OMNIA algorithm
-
Community
More than 2000 people involved in chats
and social media
-
Strong team
Professional endocrinologists, developers designers and managers from France, Austria and Russia.
FUTURE ECOSYSTEM
-
Online doctor support
Stay connected with your doctor online in the app
-
Multiple devices
Smartphones, watches & web
-
Type 2 ready
Covers patients with both T1D & T2D
-
Public Monitoring
Integration with health care systems
-
More pumps & pens
Adding new pumps, pens & sensors to fit more users
-
Growing community
To help each other and share usage tips
-
Child control
Parents are watching after child's compensation
Tech
To develop the final algorithm we first had to create several unique technologies
-
Metabolism simulator
The simulator allowed us to generate more than 100 million values for training the neural network, giving us training to implement the glucose prediction by the neural network.
-
Carbohydrate absorption monitoring
A detailed analysis of carbohydrate digestion allows you to achieve accuracy in calculating the coefficients and efficiently process information about carbohydrates.
-
Neural network training platform
A platform developed by the OMNIA team for building various neural network architectures designed to build, train and use neural networks. Based on this platform, a suitable neural network architecture was created to calculate the sensitivity to insulin, carbohydrates and natural glucose growth (coefficients).
OMNIA
In Numbers
84%
TIME
IN RANGE*
2000+
COMMUNITY MEMBERS
8
PROFESSIONALS
IN TEAM
7
YEARS OF DEVELOPMENT
* Time in range - time in the target range of 3.9-10 mmol / L (70-180 mg / dL).
** Simulation tests. Clinical trials stage.
Contact us
• Dubai, UAE
Office 1305, South Tower,
Dubai Science Park, Dubai, UAE